Advertisement
Screener

Ghost Tree Capital, LLC Historic Quarter Change: USA Stocks, Sold Out

Ghost Tree Capital, LLC historic quarter change: USA Stocks, Sold out

In share positions in stocks (listed in the US), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 144 positions, added to 89, reduced 77 and sold out of 127.

  • Q3 2024: Stock BHVN; Country of operation United States; Class COM; Shares before 490,000.
  • Q3 2024: Stock ALNY; Country of operation United States; Class COM; Shares before 22,500.
  • Q3 2024: Stock ACAD; Country of operation United States; Class COM; Shares before 225,000.
  • Q3 2024: Stock CABA; Country of operation United States; Class COM; Shares before 370,899.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2024BHVN
BIOHAVEN LTD
United StatesCOM490,0000-490,000$17,007,900$0-$17,007,9002024-11-14
Q3 2024ALNY
ALNYLAM PHARMACEUTICALS INC
United StatesCOM22,5000-22,500$5,467,500$0-$5,467,5002024-11-14
Q3 2024ACAD
ACADIA PHARMACEUTICALS INC
United StatesCOM225,0000-225,000$3,656,250$0-$3,656,2502024-11-14
Q3 2024CABA
CABALETTA BIO INC
United StatesCOM370,8990-370,899$2,774,325$0-$2,774,3252024-11-14
Q3 2024CYTK
CYTOKINETICS INC
United StatesCOM NEW33,2000-33,200$1,798,776$0-$1,798,7762024-11-14
Q3 2024KRYS
KRYSTAL BIOTECH INC
United StatesCOM8,5000-8,500$1,560,940$0-$1,560,9402024-11-14
Q3 2024ARWR
ARROWHEAD PHARMACEUTICALS IN
United StatesCOM35,0000-35,000$909,650$0-$909,6502024-11-14
Q3 2024SGMT
SAGIMET BIOSCIENCES INC
United StatesCOM SER A225,0000-225,000$769,500$0-$769,5002024-11-14
Q3 2024MGNX
MACROGENICS INC
United StatesCOM150,0000-150,000$637,500$0-$637,5002024-11-14
Q3 2024PMVP
PMV PHARMACEUTICALS INC
United StatesCOM375,0000-375,000$607,500$0-$607,5002024-11-14
Q3 2024PTCT
PTC THERAPEUTICS INC
United StatesCOM19,0000-19,000$581,020$0-$581,0202024-11-14
Q3 2024NTLA
INTELLIA THERAPEUTICS INC
United StatesCOM25,0000-25,000$559,500$0-$559,5002024-11-14
Q3 2024ANTX
AN2 THERAPEUTICS INC
United StatesCOM219,3310-219,331$471,562$0-$471,5622024-11-14
Q3 2024CTMX
CYTOMX THERAPEUTICS INC
United StatesCOM300,0000-300,000$366,000$0-$366,0002024-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet